These carcinogens from tobacco (like NNK) also acts as a site-selective high affinity agonist for the α7 nicotinic acetylcholine receptor or nAch (-5.47 Kcal/Mol), which controls the development of a significant small cell lung carcinoma by stimulating the secretion of serotonin. Here, CHRNA7 is linked to small cell lung carcinoma.